Both items have been developed from population surveys aimed at measuring disabilities (McDougall & Miller 2003).
Two-tier items have been developed and tested for several subject areas.
Lists of allowable items have been developed (although companies have taken advantage of lax implementation at ports).
The original General Health Questionnaire GHQQ) comprised 60 items and versions with fewer items have been developed from this, e.g. the GHQ - 30, GHQ - 28 and GHQ- 12 [ 1, 2].
Brief one sentence HL and numeracy screening items have been developed and tested, against various formal HL assessment tools, to quickly assess patients' HL and numeracy skills in busy clinical settings [ 25– 28].
These six items have been developed based on Sackett and colleagues' description of the EBP process, including formulating critical clinical questions, searching for relevant knowledge in databases and other information sources such as discussing with colleagues, critically appraising and compiling best knowledge, and finally implementing evidence and evaluating practice performance [ 5].
Therefore, a short version of 33 items has been developed and validated.
A new version of the CEQ (CEQ 2) comprising of 25 items has been developed and is currently being validated in Sweden.
For all clinical projects within the framework of CNHF, a harmonized basic clinical data set consisting of 190 items has been developed including echocardiographic parameters.
In collaboration with the CONSORT Consolidated Standardss of Reporting Trials) Group, a checklist of essential items has been developed that authors should consult when reporting the main results of an RCT in any journal or conference abstract [ 9, 10].
These items had been developed in tandem with a more traditional survey instrument on the topic of commercialization administered separately to the Stem Cell Network [ 30], which, as shown below, provides new comparative insights when paired with this study.
